Clinical Drug Experience Knowledgebase

Breast Neoplasms (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 2)

Gastrointestinal Stromal Tumors (Phase 2)

Hodgkin Disease (Phase 3)

Hypersensitivity (Phase 2)

Kidney Failure, Chronic (Phase 1)

Leukemia (Phase 3)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)

Leukemia, Lymphoid (Phase 3)

Lymphoma, Non-Hodgkin (Phase 3)

Lymphoproliferative Disorders (Phase 3)

Multiple Myeloma (Phase 3)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 3)

Ovarian Neoplasms (Phase 2)

Rectal Neoplasms (Phase 2)

Renal Insufficiency (Phase 1)

Stomach Neoplasms (Phase 2)

Thrombocytopenia (Phase 2)

Urinary Bladder Neoplasms (Phase 2)